Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional analysis of kinin antagonists.

F Lembeck1, T Griesbacher

  • 1Department of Experimental and Clinical Pharmacology, University of Graz, Austria.

Journal of Cardiovascular Pharmacology
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation Of Medicines For Reimbursement By The National Social Insurance Institutions In Austria.

Clinical therapeutics·2016
Same author

Kallikrein inhibitors limit kinin B(2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats.

British journal of pharmacology·2008
Same author

Effects of the non-peptide B2 receptor antagonist FR173657 in models of visceral and cutaneous inflammation.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2000
Same author

Different modes of action of morphine and epibatidine in Straub tail reactions in mice.

Arzneimittel-Forschung·2000
Same author

Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors.

Pharmacology·2000
Same author

5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.

Immunopharmacology·1999
Same journal

Imipramine Can Block Human Cardiac H1-Histamine Receptors.

Journal of cardiovascular pharmacology·2026
Same journal

Ivabradine in the Treatment of POTS Before and After COVID-19 Pandemic: A Systematic Review and Meta-Analysis.

Journal of cardiovascular pharmacology·2026
Same journal

Mineralocorticoid receptor antagonists in managing hypertension: a link with diurnal patterns of blood pressure.

Journal of cardiovascular pharmacology·2026
Same journal

The Cardiac Sarcomere: From development of heritable cardiomyopathies to gene and precision therapies.

Journal of cardiovascular pharmacology·2026
Same journal

Efficacy and Safety of Lorundrostat for Uncontrolled and Treatment-resistant Hypertension: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Journal of cardiovascular pharmacology·2026
Same journal

Safety and Efficacy of Lorundrostat in Uncontrolled Hypertension: A Systematic Review and Meta-Analysis.

Journal of cardiovascular pharmacology·2026
See all related articles

Peptide analogs of bradykinin (BK) effectively block BK

Area of Science:

  • Pharmacology
  • Neuroscience
  • Biochemistry

Background:

  • Bradykinin (BK) plays a role in smooth muscle contraction and inflammatory processes.
  • BK also stimulates C fiber afferent neurons, contributing to pain and neurogenic inflammation.
  • Development of specific BK antagonists is crucial for therapeutic interventions.

Purpose of the Study:

  • To evaluate the efficacy of a novel peptide analog, B4310, as a bradykinin antagonist.
  • To investigate the antagonism of BK's actions on smooth muscle and neuronal preparations.
  • To determine the potency and duration of action of B4310.

Main Methods:

  • Synthesis and characterization of Lys-Lys-[Hyp3, Thi5.8, D-Phe7]-BK (B4310).
  • In vitro studies using rat uterus and duodenum smooth muscle preparations.

Related Experiment Videos

  • In vivo and ex vivo studies using rabbit ear reflex and isolated rabbit iris sphincter muscle preparations.
  • Dose-response analysis and pA2 value determination.

    • Main Results:

    • B4310 demonstrated potent antagonism of BK in rat smooth muscle preparations with pA2 values > 7.0.
    • B4310 antagonized BK-induced stimulation of C fiber afferent neurons in rabbit preparations.
    • A parallel shift in BK dose-response curves indicated competitive antagonism.
    • Antagonist action was specific and dose-dependent, but short-lived due to rapid peptidase inactivation.

    Conclusions:

    • The peptide analog B4310 is a potent bradykinin antagonist in both smooth muscle and neuronal systems.
    • B4310 effectively blocks BK-mediated inflammatory and neuronal signaling.
    • Rapid inactivation by peptidases limits the duration of B4310's action, suggesting potential for modification to improve stability.